Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Samonigg

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Wiener Medizinische Wochenschrift (1946)|December 31, 1985
[Value of hormone therapy in metastasizing breast cancer]H Samonigg
Wiener Medizinische Wochenschrift (1946)|November 30, 1984
[Endogenous creatinine clearing during cytostatic therapy]F Sterz, J Borkenstein, H Samonigg
Wiener Klinische Wochenschrift|April 2, 1982
[Clinical features and therapeutic management of male breast cancer (author's transl)]H Samonigg, W Fereberger, P Steindorfer
Wiener Medizinische Wochenschrift (1946)|November 15, 1984
[Pneumatic cold cap for the prevention of doxorubicin-induced alopecia]H Samonigg, W Fereberger, E Biffl
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancerR Jakesz, H Hausmaninger, H Samonigg
European Journal of Haematology. Supplementum|January 1, 1987
Combination chemotherapy with aclarubicin in metastatic breast cancerH Simader, H Hausmaninger, W Fereberger, et al.
Wiener Medizinische Wochenschrift (1946)|July 31, 1984
[Emergencies in oncology]W Fereberger, M Neubauer, H Samonigg, et al.
The British Journal of Dermatology|February 3, 2009
In vivo confocal laser scanning microscopy in the diagnosis of melanocytic skin tumoursA Gerger, R Hofmann-Wellenhof, H Samonigg, et al.
MMW, Munchener Medizinische Wochenschrift|May 14, 1982
[Immunoreactive serum calcitonin in breast cancer]W Fereberger, G Leb, A Passath, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Aclarubicin in advanced thyroid cancer: a phase II studyH Samonigg, D K Hossfeld, J Spehn, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Wiener Medizinische Wochenschrift (1946)|December 31, 1985
[Value of hormone therapy in metastasizing breast cancer]H Samonigg
Wiener Medizinische Wochenschrift (1946)|November 30, 1984
[Endogenous creatinine clearing during cytostatic therapy]F Sterz, J Borkenstein, H Samonigg
Wiener Klinische Wochenschrift|April 2, 1982
[Clinical features and therapeutic management of male breast cancer (author's transl)]H Samonigg, W Fereberger, P Steindorfer
Wiener Medizinische Wochenschrift (1946)|November 15, 1984
[Pneumatic cold cap for the prevention of doxorubicin-induced alopecia]H Samonigg, W Fereberger, E Biffl
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancerR Jakesz, H Hausmaninger, H Samonigg
European Journal of Haematology. Supplementum|January 1, 1987
Combination chemotherapy with aclarubicin in metastatic breast cancerH Simader, H Hausmaninger, W Fereberger, et al.
Wiener Medizinische Wochenschrift (1946)|July 31, 1984
[Emergencies in oncology]W Fereberger, M Neubauer, H Samonigg, et al.
The British Journal of Dermatology|February 3, 2009
In vivo confocal laser scanning microscopy in the diagnosis of melanocytic skin tumoursA Gerger, R Hofmann-Wellenhof, H Samonigg, et al.
MMW, Munchener Medizinische Wochenschrift|May 14, 1982
[Immunoreactive serum calcitonin in breast cancer]W Fereberger, G Leb, A Passath, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Aclarubicin in advanced thyroid cancer: a phase II studyH Samonigg, D K Hossfeld, J Spehn, et al.
Pageof 8